Kelonia Therapeutics – In Vivo CAR-T Clinical Update

Summary Kelonia Therapeutics presented updated ASCO 2026 data supporting continued advancement of its in vivo CAR-T platform, which engineers CAR-T cells directly inside patients using targeted lentiviral delivery technology. What Happened Kelonia shared updated clinical progress from its in vivo CAR-T platform at ASCO 2026.…